ARCT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ARCTArcturus Therapeutics Holdings Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ARCTArcturus Therapeutics Holdings Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closesMethod ›

Moved together

ARCTwithLLY

Uncorrelated: r 0.17 · 500D.

No shared co-movers.

ARCT, solidLLY, hatchedr = correlationBar = r to r 0.75Source: daily closes

ARCTArcturus Therapeutics Holdings Inc.

10.36▲+10.67%· post 10.36· delayed

Mkt cap$269.8MRevenue$18MQ3 FY26Revenue$82MFY25

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,361.50· delayed

After hoursNov 6 '26delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 6 '26delayed

ARCTArcturus Therapeutics Holdings Inc.

LLYELI Lilly & Co

10.36▲+10.67%post 10.36delayed

Price

1,360.90▼−0.28%post 1,361.50delayed

$269.8M

Mkt cap

$1.2T

Q3 FY26$18M

Revenue

$24.4BQ3 FY26

FY25$82M

Revenue

$65.2BFY25

ARCT10.36▲+10.67%vsLLY1,360.90▼−0.28%After hoursNov 6 '26delayed